Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Hardisson
The miR-200 Family Controls -Tubulin III Expression and Is Associated With Paclitaxel-Based Treatment Response and Progression-Free Survival in Ovarian Cancer Patients
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Hypermethylation of the microRNA miR-124, miR-125b, miR-127, and miR-129 in Ovarian Carcinoma Is Involved in Suppression of Their Expression and Associated With Both the Development and Progression of Ovarian Cancer
Almanac of Clinical Medicine
hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance
Journal of Cancer Therapy
Ovarian Cancer Cell Invasiveness Is Associated With Discordant Exosomal Sequestration of Let-7 miRNA and miR-200
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy
PLoS ONE
Multidisciplinary
Prognosis and Conditional Disease-Free Survival Among Patients With Ovarian Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Increased Expression of H-Prune Is Associated With Tumor Progression and Poor Survival in Gastric Cancer
Cancer Science
Cancer Research
Medicine
Oncology
P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Metformin Intake Is Associated With Better Survival in Ovarian Cancer
Cancer
Cancer Research
Oncology
Overexpression of Class III Β-Tubulin, Sox2, and Nuclear Survivin Is Predictive of Taxane Resistance in Patients With Stage III Ovarian Epithelial Cancer
BMC Cancer
Cancer Research
Oncology
Genetics